Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors

© 2016 Informa UK Limited, trading as Taylor & Francis Group. Objective: Current chemotherapy treatments available for treating high-grade brain tumors, Temozolomide (TMZ) or Bevacizumab (BEV), not only have specific anti-tumor mechanisms, but also have an effect on mitochondria. However, effe...

Full description

Saved in:
Bibliographic Details
Main Authors: Nanegrungsunk D., Apaijai N., Yarana C., Sripetchwandee J., Limpastan K., Watcharasaksilp W., Vaniyapong T., Chattipakorn N., Chattipakorn S.
Format: Journal
Published: 2017
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84978422190&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/41962
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-41962
record_format dspace
spelling th-cmuir.6653943832-419622017-09-28T04:24:26Z Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors Nanegrungsunk D. Apaijai N. Yarana C. Sripetchwandee J. Limpastan K. Watcharasaksilp W. Vaniyapong T. Chattipakorn N. Chattipakorn S. © 2016 Informa UK Limited, trading as Taylor & Francis Group. Objective: Current chemotherapy treatments available for treating high-grade brain tumors, Temozolomide (TMZ) or Bevacizumab (BEV), not only have specific anti-tumor mechanisms, but also have an effect on mitochondria. However, effects of both drugs on mitochondria isolated from human brain tumors have not been thoroughly investigated. This study determined the direct effects of TMZ and BEV as well as the neurotoxic condition (calcium overload), on the function of mitochondria and compared these effects on mitochondria isolated from low- and high-grade human brain tumors. Methods: Mitochondria were isolated from either low- or high-grade human primary brain tumors. Calcium overload conditions (100 or 200 μM), TMZ (300 μM), and BEV (2 mg/mL) were applied to isolated mitochondria from low- and high-grade brain tumors. Following the treatment, mitochondrial function, including reactive oxygen species production, membrane potential changes, and swelling, were determined. The mitochondrial morphology was also examined. Results: In calcium overload conditions, mitochondrial dysfunction was only found to have occurred in low-grade tumors. In TMZ and BEV treatment, BEV, rather than TMZ, caused greater membrane depolarization and mitochondrial swelling in both grades of brain tumors. Conclusions: TMZ and BEV can directly cause the dysfunction of mitochondria isolated from human brain tumors. However, BEV has a greater ability to disturb mitochondrial function in mitochondria isolated from human brain tumors than either TMZ or calcium overload conditions. 2017-09-28T04:24:26Z 2017-09-28T04:24:26Z 2016-04-02 Journal 01616412 2-s2.0-84978422190 10.1080/01616412.2015.1114233 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84978422190&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41962
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
description © 2016 Informa UK Limited, trading as Taylor & Francis Group. Objective: Current chemotherapy treatments available for treating high-grade brain tumors, Temozolomide (TMZ) or Bevacizumab (BEV), not only have specific anti-tumor mechanisms, but also have an effect on mitochondria. However, effects of both drugs on mitochondria isolated from human brain tumors have not been thoroughly investigated. This study determined the direct effects of TMZ and BEV as well as the neurotoxic condition (calcium overload), on the function of mitochondria and compared these effects on mitochondria isolated from low- and high-grade human brain tumors. Methods: Mitochondria were isolated from either low- or high-grade human primary brain tumors. Calcium overload conditions (100 or 200 μM), TMZ (300 μM), and BEV (2 mg/mL) were applied to isolated mitochondria from low- and high-grade brain tumors. Following the treatment, mitochondrial function, including reactive oxygen species production, membrane potential changes, and swelling, were determined. The mitochondrial morphology was also examined. Results: In calcium overload conditions, mitochondrial dysfunction was only found to have occurred in low-grade tumors. In TMZ and BEV treatment, BEV, rather than TMZ, caused greater membrane depolarization and mitochondrial swelling in both grades of brain tumors. Conclusions: TMZ and BEV can directly cause the dysfunction of mitochondria isolated from human brain tumors. However, BEV has a greater ability to disturb mitochondrial function in mitochondria isolated from human brain tumors than either TMZ or calcium overload conditions.
format Journal
author Nanegrungsunk D.
Apaijai N.
Yarana C.
Sripetchwandee J.
Limpastan K.
Watcharasaksilp W.
Vaniyapong T.
Chattipakorn N.
Chattipakorn S.
spellingShingle Nanegrungsunk D.
Apaijai N.
Yarana C.
Sripetchwandee J.
Limpastan K.
Watcharasaksilp W.
Vaniyapong T.
Chattipakorn N.
Chattipakorn S.
Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
author_facet Nanegrungsunk D.
Apaijai N.
Yarana C.
Sripetchwandee J.
Limpastan K.
Watcharasaksilp W.
Vaniyapong T.
Chattipakorn N.
Chattipakorn S.
author_sort Nanegrungsunk D.
title Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
title_short Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
title_full Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
title_fullStr Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
title_full_unstemmed Bevacizumab is superior to Temozolomide in causing mitochondrial dysfunction in human brain tumors
title_sort bevacizumab is superior to temozolomide in causing mitochondrial dysfunction in human brain tumors
publishDate 2017
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84978422190&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/41962
_version_ 1681422099548209152